RecruitingPhase not listedNCT04706663
Precision-Based Genomics in Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Boston, MA · +10 more sites
Prostate Cancer clinical trials in Boston, MA
46 recruiting prostate cancer studies with a site in Boston, MA.
RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Boston, MA · +22 more sites
RecruitingPhase 1NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: AstraZeneca
Boston, MA · +11 more sites
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Boston, MA · Newton, MA · +42 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Boston, MA · +29 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Boston, MA · +14 more sites
RecruitingPhase 4NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Sponsor: Blue Earth Diagnostics
Boston, MA · +5 more sites
RecruitingNot applicableNCT07059884
Distance-Based Exercise to Preserve Function and Prevent Disability
Sponsor: Alliance for Clinical Trials in Oncology
Boston, MA · +22 more sites
RecruitingNot applicableNCT06496256
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Sponsor: Palette Life Sciences, Inc.
Boston, MA · +10 more sites
RecruitingPhase 1 / Phase 2NCT06800313
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Boston, MA · +16 more sites
RecruitingPhase 1NCT06801236
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Acerand Therapeutics (Hong Kong) Limited
Boston, MA · +7 more sites
RecruitingPhase 1 / Phase 2NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Boston, MA · +10 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Boston, MA · +58 more sites
RecruitingNot applicableNCT07729150
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
Sponsor: Dana-Farber Cancer Institute
Boston, MA
RecruitingPhase 2NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Sponsor: AstraZeneca
Boston, MA · +16 more sites
RecruitingNot applicableNCT06202820
CV CARE: CardioVascular Care in PC Patients
Sponsor: Dana-Farber Cancer Institute
Boston, MA
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
Boston, MA · +33 more sites
RecruitingPhase 1NCT07006727
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Sponsor: Novartis Pharmaceuticals
Boston, MA · +3 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
Boston, MA · +20 more sites
RecruitingPhase 1NCT07581184
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Aktis Oncology, Inc.
Boston, MA · +5 more sites
RecruitingNot applicableNCT05804318
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
Sponsor: Varian, a Siemens Healthineers Company
Boston, MA · +4 more sites
RecruitingPhase not listedNCT00756665
Prostate Active Surveillance Study
Sponsor: University of Washington
Boston, MA · +9 more sites
RecruitingNot applicableNCT04188535
Serial MRI Scans During Radiation Therapy
Sponsor: Dana-Farber Cancer Institute
Boston, MA
RecruitingPhase 1 / Phase 2NCT07192614
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Boston, MA · +5 more sites
RecruitingPhase 2NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Sponsor: Prostate Cancer Clinical Trials Consortium
Boston, MA · +7 more sites
RecruitingPhase 1 / Phase 2NCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Sponsor: Novartis Pharmaceuticals
Boston, MA · +20 more sites
RecruitingPhase 1NCT06966024
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Sponsor: Deciphera Pharmaceuticals, LLC
Boston, MA · +7 more sites
RecruitingPhase not listedNCT05463796
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Sponsor: Dana-Farber Cancer Institute
Boston, MA
RecruitingPhase 1NCT06067841
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Sponsor: Bristol-Myers Squibb
Boston, MA · +7 more sites
RecruitingPhase 2NCT05765500
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Sponsor: Dana-Farber Cancer Institute
Boston, MA · Foxborough, MA
RecruitingNot applicableNCT05327465
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Sponsor: Dana-Farber Cancer Institute
Boston, MA
RecruitingPhase 3NCT06274047
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Sponsor: M.D. Anderson Cancer Center
Boston, MA · +5 more sites
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
Boston, MA · +23 more sites
RecruitingPhase 1 / Phase 2NCT04946370
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Sponsor: Weill Medical College of Cornell University
Boston, MA · +3 more sites
RecruitingPhase 2 / Phase 3NCT04787744
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Sponsor: VA Office of Research and Development
Boston, MA · +19 more sites
RecruitingPhase 1 / Phase 2NCT05785741
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Boston, MA · +14 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Boston, MA · +13 more sites
RecruitingPhase 1 / Phase 2NCT06267729
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Boston, MA · +11 more sites
RecruitingPhase 4NCT06099093
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingPhase 4NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Sponsor: Guerbet
Boston, MA · +13 more sites
RecruitingNot applicableNCT05926102
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
Sponsor: VA Office of Research and Development
Boston, MA
RecruitingNot applicableNCT06398639
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Sponsor: Adam S. Kibel, MD
Boston, MA · +3 more sites
RecruitingPhase 1NCT06062745
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingPhase not listedNCT05129605
Prostate Cancer Genetic Risk Evaluation and Screening Study
Sponsor: Massachusetts General Hospital
Boston, MA
Not yet recruitingEarly Phase 1NCT07781852
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
Sponsor: Lumina Pharmaceuticals Inc
Boston, MA · +2 more sites
Not yet recruitingNot applicableNCT07768917
Training on Systemic and Organ Spec. PM in PC
Sponsor: Massachusetts General Hospital
Boston, MA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.